Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Kimberly-Clark, which owns Huggies and Kleenex, is acquiring Kenvue, the maker of Tylenol, in a cash and stock deal worth ...

Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Shareholders of Kimberly-Clark will own about 54% of the combined company. Two years ago, Johnson & Johnson spun off its ...

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...